Literature DB >> 17917471

Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases.

Martin Härter1, Harald Baumeister, Katrin Reuter, Frank Jacobi, Michael Höfler, Jürgen Bengel, Hans-Ulrich Wittchen.   

Abstract

BACKGROUND: Although it is well established that chronic somatic diseases are significantly associated with a wide range of psychopathology, it remains unclear to what extent subjects with chronic somatic diseases are at increased risk of experiencing mental disorders. The present epidemiological study investigates age- and sex-adjusted 12-month prevalence rates of mental disorders in patients with cancer, and musculoskeletal, cardiovascular and respiratory tract diseases, based on comprehensive physicians' diagnoses and compared with physically healthy probands.
METHODS: Prevalence rates were calculated from two large epidemiological surveys. These studies investigated inpatients and patients from the general population with cancer (n = 174) and musculoskeletal (n = 1,416), cardiovascular (n = 915) and respiratory tract diseases (n = 453) as well as healthy controls (n = 1,083). The prevalence rates were based on the Munich Composite International Diagnostic Interview, a standardized interview for the assessment of mental disorders.
RESULTS: Prevalence rates were very similar for inpatients (43.7%) and patients from the general population (42.2%). The adjusted odds ratios (OR) of patients with chronic somatic diseases were significantly elevated for mental disorders in comparison with healthy probands (OR: 2.2). Mood, anxiety and somatoform disorders were most frequent. The prevalence rates did not differ significantly between the somatic index diseases. The number of somatic diseases per patient had a higher association with mental disorders.
CONCLUSIONS: There is a strong relationship between chronic somatic diseases and mental disorders. A future task is to improve the care of mental disorders in patients with chronic physical illness, specifically with multimorbid conditions. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17917471     DOI: 10.1159/000107563

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  42 in total

1.  NeuroAIDS: a watershed for mental health and nervous system disorders.

Authors:  Jennifer A McCombe; Farshid Noorbakhsh; Craig Buchholz; Michael Trew; Christopher Power
Journal:  J Psychiatry Neurosci       Date:  2009-03       Impact factor: 6.186

2.  [Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)].

Authors:  F Jacobi; M Höfler; J Strehle; S Mack; A Gerschler; L Scholl; M A Busch; U Maske; U Hapke; W Gaebel; W Maier; M Wagner; J Zielasek; H-U Wittchen
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

Review 3.  Pharmacological management of depression in patients with cancer: practical considerations.

Authors:  Riccardo G V Torta; Valentina Ieraci
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

4.  Advanced cancer as a risk for major depressive episodes.

Authors:  Fremonta Meyer; Kalen Fletcher; Holly G Prigerson; Ilana M Braun; Paul K Maciejewski
Journal:  Psychooncology       Date:  2014-11-12       Impact factor: 3.894

5.  Use of health care services by people with mental illness: secondary data from three statutory health insurers and the German Statutory Pension Insurance Scheme.

Authors:  Wolfgang Gaebel; Sandra Kowitz; Jürgen Fritze; Jürgen Zielasek
Journal:  Dtsch Arztebl Int       Date:  2013-11-22       Impact factor: 5.594

Review 6.  Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review.

Authors:  N Hutter; A Schnurr; H Baumeister
Journal:  Diabetologia       Date:  2010-08-11       Impact factor: 10.122

7.  Temporal associations between physical illnesses and mental disorders--results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  S Patricia Chou; Boji Huang; Risë Goldstein; Bridget F Grant
Journal:  Compr Psychiatry       Date:  2013-03-20       Impact factor: 3.735

8.  Evaluation of two group therapies to reduce fear of progression in cancer patients.

Authors:  Peter Herschbach; Katrin Book; Andreas Dinkel; Petra Berg; Sabine Waadt; Gabriele Duran; Ursula Engst-Hastreiter; Gerhard Henrich
Journal:  Support Care Cancer       Date:  2009-10-29       Impact factor: 3.603

9.  Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH).

Authors:  Frank Jacobi; Michael Höfler; Jens Siegert; Simon Mack; Anja Gerschler; Lucie Scholl; Markus A Busch; Ulfert Hapke; Ulrike Maske; Ingeburg Seiffert; Wolfgang Gaebel; Wolfgang Maier; Michael Wagner; Jürgen Zielasek; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2014-04-11       Impact factor: 4.035

10.  The role of public health in addressing racial and ethnic disparities in mental health and mental illness.

Authors:  Annelle B Primm; Melba J T Vasquez; Robert A Mays; Doreleena Sammons-Posey; Lela R McKnight-Eily; Letitia R Presley-Cantrell; Lisa C McGuire; Daniel P Chapman; Geraldine S Perry
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.